Evidence of regulatory myeloid dendritic cells and circulating inflammatory epidermal dendritic cells-like modulated by Toll-like receptors 2 and 7/8 in adults with atopic dermatitis

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
INTERNATIONAL JOURNAL OF DERMATOLOGY, v.56, n.6, p.630-635, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Backgroud Atopic dermatitis (AD) is a chronic, inflammatory skin disease characterized by intense pruritus and xerosis. Dendritic cells (DC) play an essential role in tissue inflammation in atopic dermatitis (AD) skin, especially the inflammatory epidermal dendritic cells (IDEC), a particular subset of myeloid dendritic cells (mDC). The aim of the present study was to assess the phenotype and function of mDC and circulating IDEC-like in peripheral blood mononuclear cells (PBMC) of adults with AD. Methods We selected 21 AD patients and 21 non-AD controls, age and gender matched. Expressions of Fc epsilon RI, CD36, TNF, IFN-gamma , and IL-10 in mDC were analyzed by flow cytometry under various stimuli, such as staphylococcal enterotoxin B (SEB), TLR2 (Pam3CSK4), TLR4 (LPS), and TLR7/8 (CL097) agonists. Results The most prominent findings in AD patients were: (i) enhanced frequency of IL-10 under TLR4 (LPS), and decreased frequency of IFN-gamma and TNF under TLR2 (Pam3CSK4) and 7/8 (CL097) stimulation in classic mDC; (ii) elevation of circulating IDEC-like frequency with TLR2 (Pam3CSK4) stimuli, augmented frequency of IFN-gamma in nonstimulated condition, and of IL-10 under TLR7/8 (CL097) stimuli in IDEC-like population. Conclusions In AD individuals, classic mDC showed an immunomodulatory profile, favoring tolerance in a combined action with IDEC-like, and inducing Th1 polarization. Our findings indicate a potential role of IDEC-like in the maintenance of inflammation in atopic dermatitis patients; moreover, IDEC-like may exert a regulatory impact on T cells of AD individuals through IL-10, often induced by agonist mimicking single stranded RNA virus.
Palavras-chave
Referências
  1. Bieber T, 2007, IMMUNOBIOLOGY, V212, P499, DOI 10.1016/j.imbio.2007.03.001
  2. Bieber T, 2011, CLIN REV ALLERG IMMU, V41, P254, DOI 10.1007/s12016-010-8224-0
  3. Domingues R, 2015, BRIT J DERMATOL, V172, P48, DOI 10.1111/bjd.13214
  4. Domingues R, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0938-1
  5. Gros E, 2012, CLIN EXP ALLERGY, V42, P1161, DOI 10.1111/j.1365-2222.2012.03964.x
  6. Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006
  7. Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x
  8. HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44
  9. Hayashi Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-29
  10. Kuo IH, 2013, J ALLERGY CLIN IMMUN, V131, P266, DOI 10.1016/j.jaci.2012.12.1563
  11. Leung DYM, 2013, ALLERGOL INT, V62, P151, DOI 10.2332/allergolint.13-RAI-0564
  12. Moller-Larsen S, 2008, THORAX, V63, P1064, DOI 10.1136/thx.2007.094128
  13. Novak N, 2004, J ALLERGY CLIN IMMUN, V113, P949, DOI 10.1016/j.jaci.2004.02.005
  14. Novak N, 2012, J ALLERGY CLIN IMMUN, V129, P879, DOI 10.1016/j.jaci.2012.01.062
  15. Novak N, 2010, J ALLERGY CLIN IMMUN, V125, P50, DOI 10.1016/j.jaci.2009.11.019
  16. Orfali RL, 2009, EXP DERMATOL, V18, P628, DOI 10.1111/j.1600-0625.2009.00842.x
  17. Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
  18. Sato K., 2007, ALLERGOL INT, V56, P183, DOI 10.2332/allergolint.R-06-139
  19. Skabytska Y, 2016, SEMIN IMMUNOPATHOL, V38, P29, DOI 10.1007/s00281-015-0544-y
  20. Stockwin LH, 2000, IMMUNOL CELL BIOL, V78, P91, DOI 10.1046/j.1440-1711.2000.00888.x
  21. Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186
  22. vansEgmond M, 2015, IMMUNOL REV, V268, P311
  23. Vittorakis S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231036
  24. Wollenberg A, 2013, ALLERGY, V68, P1509, DOI 10.1111/all.12324
  25. Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596
  26. Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225